Innovations in Vaccine Therapies - Genetic Technology TOE

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of the Genetic Technology TOE depicts trends across vaccines therapies. Committed to meet the demand for precision medicine solutions, market participants are increasingly focusing on developing vaccines therapies. Taking into account that the global vaccine market was worth more than $25 billion in revenue during 2015 and is expected to grow in the next few years with the development of novel vaccine delivery technologies, analyst insights on global vaccine markets are presented. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology tran

Table of Contents

Innovations in Vaccine Therapies - Genetic Technology TOETrend OverviewTrends in Vaccine TherapiesTechnology ProfilesInactivated Virus TechnologyCustomizable Vaccine NanoformulationsPersonalized Cancer VaccinesStrategic PerspectivesAnalyst Insights on Global Vaccine Markets AppendixPatent ScenarioPatent ScenarioIndustry Interactions

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.